rs12279261

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_181351.5(NCAM1):​c.1825+569A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.224 in 152,120 control chromosomes in the GnomAD database, including 4,891 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.22 ( 4891 hom., cov: 33)

Consequence

NCAM1
NM_181351.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.187

Publications

11 publications found
Variant links:
Genes affected
NCAM1 (HGNC:7656): (neural cell adhesion molecule 1) This gene encodes a cell adhesion protein which is a member of the immunoglobulin superfamily. The encoded protein is involved in cell-to-cell interactions as well as cell-matrix interactions during development and differentiation. The encoded protein plays a role in the development of the nervous system by regulating neurogenesis, neurite outgrowth, and cell migration. This protein is also involved in the expansion of T lymphocytes, B lymphocytes and natural killer (NK) cells which play an important role in immune surveillance. This protein plays a role in signal transduction by interacting with fibroblast growth factor receptors, N-cadherin and other components of the extracellular matrix and by triggering signalling cascades involving FYN-focal adhesion kinase (FAK), mitogen-activated protein kinase (MAPK), and phosphatidylinositol 3-kinase (PI3K). One prominent isoform of this gene, cell surface molecule CD56, plays a role in several myeloproliferative disorders such as acute myeloid leukemia and differential expression of this gene is associated with differential disease progression. For example, increased expression of CD56 is correlated with lower survival in acute myeloid leukemia patients whereas increased severity of COVID-19 is correlated with decreased abundance of CD56-expressing NK cells in peripheral blood. Alternative splicing results in multiple transcript variants encoding distinct protein isoforms. [provided by RefSeq, Aug 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.399 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NCAM1NM_181351.5 linkc.1825+569A>G intron_variant Intron 14 of 19 ENST00000316851.12 NP_851996.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NCAM1ENST00000316851.12 linkc.1825+569A>G intron_variant Intron 14 of 19 5 NM_181351.5 ENSP00000318472.8

Frequencies

GnomAD3 genomes
AF:
0.224
AC:
34054
AN:
152002
Hom.:
4876
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.403
Gnomad AMI
AF:
0.234
Gnomad AMR
AF:
0.192
Gnomad ASJ
AF:
0.166
Gnomad EAS
AF:
0.0700
Gnomad SAS
AF:
0.0503
Gnomad FIN
AF:
0.0906
Gnomad MID
AF:
0.241
Gnomad NFE
AF:
0.169
Gnomad OTH
AF:
0.237
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.224
AC:
34107
AN:
152120
Hom.:
4891
Cov.:
33
AF XY:
0.217
AC XY:
16116
AN XY:
74380
show subpopulations
African (AFR)
AF:
0.404
AC:
16742
AN:
41464
American (AMR)
AF:
0.192
AC:
2934
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.166
AC:
574
AN:
3468
East Asian (EAS)
AF:
0.0702
AC:
363
AN:
5174
South Asian (SAS)
AF:
0.0499
AC:
241
AN:
4828
European-Finnish (FIN)
AF:
0.0906
AC:
960
AN:
10598
Middle Eastern (MID)
AF:
0.245
AC:
72
AN:
294
European-Non Finnish (NFE)
AF:
0.169
AC:
11515
AN:
67990
Other (OTH)
AF:
0.233
AC:
493
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1249
2497
3746
4994
6243
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
322
644
966
1288
1610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.191
Hom.:
9844
Bravo
AF:
0.242
Asia WGS
AF:
0.0790
AC:
273
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
1.6
DANN
Benign
0.44
PhyloP100
-0.19
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12279261; hg19: chr11-113106455; API